The Goldman Sachs Group Begins Coverage on Ardent Health (NYSE:ARDT)

Equities research analysts at The Goldman Sachs Group initiated coverage on shares of Ardent Health (NYSE:ARDT) in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The firm set a “neutral” rating and a $19.00 price target on the stock. The Goldman Sachs Group’s price target indicates a potential upside of 31.36% from the stock’s current price.

A number of other research firms have also issued reports on ARDT. JPMorgan Chase & Co. reduced their price target on shares of Ardent Health from $18.00 to $15.00 and set a “neutral” rating for the company in a research report on Monday, August 11th. KeyCorp lowered their price objective on Ardent Health from $24.00 to $20.00 and set an “overweight” rating on the stock in a research report on Thursday, August 7th. UBS Group started coverage on shares of Ardent Health in a report on Wednesday, September 10th. They set a “buy” rating and a $17.00 target price for the company. Bank of America cut shares of Ardent Health from a “neutral” rating to an “underperform” rating and decreased their target price for the company from $15.50 to $14.60 in a research note on Wednesday, July 16th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Ardent Health in a report on Wednesday, October 8th. Nine analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Ardent Health currently has an average rating of “Moderate Buy” and an average price target of $19.30.

Ardent Health Price Performance

Shares of ARDT stock opened at $14.46 on Tuesday. Ardent Health has a fifty-two week low of $10.10 and a fifty-two week high of $20.72. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.00 and a current ratio of 2.13. The firm has a market capitalization of $2.07 billion, a price-to-earnings ratio of 7.99, a PEG ratio of 6.32 and a beta of 0.39. The stock’s 50-day simple moving average is $13.12 and its 200-day simple moving average is $13.07.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.30 by $0.22. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.54 billion. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. As a group, equities analysts forecast that Ardent Health will post 1.23 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Ardent Health

Several large investors have recently bought and sold shares of the company. CWM LLC raised its holdings in shares of Ardent Health by 990.6% during the second quarter. CWM LLC now owns 2,203 shares of the company’s stock valued at $30,000 after acquiring an additional 2,001 shares during the last quarter. Morse Asset Management Inc purchased a new stake in shares of Ardent Health during the first quarter worth approximately $36,000. Quarry LP raised its stake in Ardent Health by 1,519.4% in the 1st quarter. Quarry LP now owns 5,020 shares of the company’s stock valued at $69,000 after purchasing an additional 4,710 shares during the last quarter. New York State Common Retirement Fund raised its stake in Ardent Health by 121.4% in the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after purchasing an additional 3,400 shares during the last quarter. Finally, Deutsche Bank AG lifted its holdings in Ardent Health by 140.1% in the 1st quarter. Deutsche Bank AG now owns 6,882 shares of the company’s stock valued at $95,000 after purchasing an additional 4,016 shares in the last quarter.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.